Document:

<Page>
                                                                    EXHIBIT 10.8

                                                          GE CAPITAL CORPORATION
                                             LIFE SCIENCE AND TECHNOLOGY FINANCE
                                                         83 WOOSTER HEIGHTS ROAD
                                                               DANBURY, CT 06810
                                                203-205-5216 / FAX: 203-205-2193

                                                                  APRIL 14, 2005

CONFIDENTIAL LOAN PROPOSAL FOR

--------------------------------------------------------------------------------

COMBINATORX, INCORPORATED

--------------------------------------------------------------------------------

SUBMITTED BY: Bill Stickle

<Page>

COMBINATORX, INCORPORATED
--------------------------------------------------------------------------------

MR. ROBERT FORRESTER
CHIEF FINANCIAL OFFICER
COMBINATORX, INCORPORATED
650 ALBANY STREET
BOSTON, MA 02118

Dear Mr. Forrester:

Pursuant to your request, General Electric Capital Corporation ("GE Capital") is
pleased to submit the following revised loan proposal for your consideration:

<Table>
<Caption>
<S>                           <C>

TRANSACTION:                  LOAN

BORROWER:                     COMBINATORX, INCORPORATED

LENDER:                       GENERAL ELECTRIC CAPITAL CORPORATION ITS
                              AFFILIATES OR ITS ASSIGNEE ("GE CAPITAL")

LOAN AMOUNT:                  $1,000,000.00

ANTICIPATED FUNDING PERIOD:   APRIL 2005 THROUGH MARCH 2006

TERM:                         36 MONTHS

PAYMENT FACTOR AND INTERVAL:  3.215463%, MONTHLY IN ARREARS

INTEREST RATE:                9.76%

EQUIPMENT (COLLATERAL):       NEW LAB AND LAB SUPPORT EQUIPMENT, COMPUTER
                              HARDWARE AND GENERAL OFFICE EQUIPMENT, FURNITURE,
                              AND SOFTWARE AND TENANT IMPROVEMENTS FOR THE
                              INTERNAL USE OF THE BORROWER. SOFT COSTS SUCH AS
                              SOFTWARE AND TENANT IMPROVEMENTS SHALL BE LIMITED
                              TO 30% OF THE LOAN AMOUNT. ALL SUCH EQUIPMENT
                              MUST BE ACCEPTABLE TO GE CAPITAL AND LOCATED
                              WITHIN THE CONTINENTAL UNITED STATES AT BORROWER
                              OWNED OR LEASED PROPERTIES.

WARRANTS:                     BORROWER SHALL ISSUE TO GE CAPITAL PREFERRED
                              STOCK WARRANTS IN THE AMOUNT OF 2.00% OF THE
                              ACTUAL LOAN AMOUNT ADVANCED AT A STRIKE PRICE
                              EQUAL TO THE MOST RECENT ROUND'S PREFERRED SHARE
                              PRICE.

OTHER CONSIDERATION:          BORROWER SHALL PROVIDE LENDER WITH A NEGATIVE
                              PLEDGE ON INTELLECTUAL PROPERTY. LENDER
                              ACKNOWLEDGES THE EXISTENCE OF A NEGATIVE PLEDGE
                              BETWEEN BORROWER AND LIGHTHOUSE CAPITAL PARTNERS
                              ("LIGHTHOUSE"). LENDER INTENDS TO ALLOW ITS
                              NEGATIVE PLEDGE WITH BORROWER TO MIRROR THE
                              NEGATIVE PLEDGE THAT BORROWER HAS WITH
                              LIGHTHOUSE.
</Table>

                          GENERAL TERMS AND CONDITIONS

OUR PROPOSAL CONTAINS THE FOLLOWING PROVISIONS AND THE LOAN PAYMENTS WE PROPOSE
ARE SPECIFICALLY BASED UPON THESE PROVISIONS AND OUR ASSUMPTIONS.

1.   MAINTENANCE AND INSURANCE: All maintenance and insurance (fire and theft,
     extended coverage and liability) are the responsibility of the Borrower.
     Borrower will be responsible for maintaining in force, all risk damage, and
     liability insurance in amounts and coverages satisfactory to GE Capital.

2.   DOCUMENTATION: GE Capital's current standard loan documentation for this
     type of collateralized loan will be used.

                                       2
<Page>

3.   INDEXING: The Interest Rate and Payment Factor will be adjusted at the time
     of funding to reflect any increase in the Lender's cost of funds, which
     shall be tied to the Federal Reserve's Three (3) year Treasury Constant
     Maturities Rate. The rate, and therefore the payment factor, assumes an
     index of 3.91%.

4.   TRANSACTION COSTS: The Borrower shall be responsible for all closing and
     transaction costs including any legal fees and inspection and/or appraisal
     costs.

5.   PROPOSAL FEE: $10,000.00. Of this Fee, $5,000.00 shall be credited on a
     prorata basis to schedules as financed and the remainder retained by GE
     Capital for application processing, underwriting and documentation. All or
     a portion of the proposal fee will be forfeited if this transaction is
     approved by GE Capital and not executed by Borrower as called for in this
     proposal. If investment approval is not obtained, the fee will be promptly
     returned to Borrower (less the cost of credit verification and
     investigation and any out of pocket expenses incurred such as appraisal
     fees, legal fees, etc.).

6.   ACCEPTANCE: By signing below, the Borrower acknowledges the terms and
     conditions of this proposal. Upon receipt of the executed proposal letter
     and accompanying fee, GE Capital shall commence its investment approval
     process.

7.   EXPIRATION: This proposal shall expire on May 3, 2005, if GE Capital has
     not received your acceptance hereof by such date.

This proposal expresses GE Capital's willingness to seek internal approval for
the transaction contemplated herein. By signing and returning this letter both
parties acknowledge that: The above proposed terms and conditions do not
constitute a commitment by GE Capital, (ii) GE Capital's senior management may
seek changes to the above terms and conditions, and (iii) GE Capital may decline
further consideration of this transaction at any point in the approval process.
GE Capital's agreement to fund the proposed transaction remains subject to and
would be preceded by completion of a legal and business due diligence, as well
as collateral and credit review and analysis, all with results satisfactory to
GE Capital and the closing of an initial funding under such transaction would be
conditioned upon the prior execution and delivery of final legal documentation
and all conditions precedent acceptable to GE Capital and its counsel and no
material adverse change in the business condition or prospects of the Company
("Material Adverse Change"). For transactions that contemplate more than one
funding, GE Capital's obligation to make each such subsequent funding would be
subject to confirmation that no Material Adverse Change has occurred.

I look forward to your early review and response. If there are any questions, I
would appreciate the opportunity to discuss this proposal in more detail at your
earliest convenience. Please do not hesitate to contact me directly at
(203) -205 -5216.

Sincerely,

PROPOSAL ACCEPTED BY:

COMBINATORX, INCORPORATED

Name:   /s/ Robert Forrester
       -------------------------------

Title: Chief Financial Officer
       -------------------------------

Date:  May 3, 2005
       -------------------------------

Federal Tax ID#:

                                       3<Page>

                                                                   EXHIBIT 10.12

March 1, 2005

Mr. Daniel Grau
42 Ashland Street
Arlington, MA 02476

Dear Dan:

On behalf of CombinatoRx, Incorporated ("the Company"), I am pleased to offer
you the position of Vice President of Commercial Operations.

1. RESPONSIBILITIES: Your responsibilities will include (i) management of the
licensing/business development, intellectual property, informatics, strategic
marketing, and new products functions; (ii) input into strategy, communications,
and PR/IR; and (iii) other appropriate tasks as necessary from time to time.
This position reports to the Chief Executive Officer and is a member of the
Executive Committee.

2. EFFECTIVE DATE: The effective date of your employment with these new
responsibilities will be on or about March 1, 2005. Your employment with the
Company will be at-will, meaning that you will not be obligated to remain
employed by the Company for any specified period of time; likewise, the Company
will not be obligated to continue your employment for any specific period and
may terminate your employment at any time, with or without cause.

3. COMPENSATION: From the effective date of your employment date your base pay
will be $8,416.67 (equivalent to $202,000 annually), paid twice per month. In
addition, you shall be eligible to earn a bonus annually during employment.
Bonuses will be earned on the basis of the Company's fiscal year. The amount of
any bonus awarded shall be based on your performance and that of the Company
against reasonably attainable goals determined annually by the CEO. Your initial
target cash bonus is up to thirty percent (30%) of your then base salary.

4. BENEFITS: You will be eligible for the Company's standard benefits package,
as well as free car parking. Benefits include participation in a company
sponsored health care plan, dental plan, life insurance, short term disability
insurance, and long term disability insurance. You will also be eligible for a
Company-matched 401(k) plan upon employment. In addition to your compensation,
you will be entitled to three (3) weeks vacation earned on a pro-rata basis.
Standard paid holidays will also be observed. The Company, however, reserves the
right to modify its employee benefit programs.

5. SEVERANCE AND TERMINATION

<Page>

FEBRUARY 2005
-- Page 2 OF 5 --

     (a)    The Company may terminate your employment hereunder, upon notice,
for Cause, meaning that there has been a reasonable, good faith determination by
the CEO that one or more of the following events has occurred, which
determination is made after notice to you specifying in reasonable detail the
nature of the Cause and a reasonable opportunity for you to be heard by the CEO.
The following shall constitute Cause for termination:

            (i)    The conviction of a felony;

            (ii)   The willful failure to perform, or gross negligence in the
     performance of, your duties and responsibilities as set forth in Section 1
     hereof, which failure or negligence continues or remains uncured after
     thirty (30) days' notice to you setting forth in reasonable detail the
     nature of such failure or negligence;

            (iii)  Material breach by you of any provision of this letter, which
     breach continues or remains uncured after thirty (30) days' notice to you
     setting forth in reasonable detail the nature of such breach; or

            (iv)   Material fraudulent conduct by you with respect to the
     Company.

In the event of termination for Cause, the Company shall have no further
obligation to you, other than for Final Compensation, in which the Company shall
pay to you (i) the Base Salary earned but not paid through the date of
termination, (ii) pay for any vacation earned but not used through the date of
termination and (iii) any business expenses incurred by you but un-reimbursed on
the date of termination, provided that such expenses and required substantiation
and documentation are submitted within ninety (90) days of termination and that
such expenses are reimbursable under Company policy (all of the foregoing,
"Final Compensation").

     (b)    The Company may terminate your employment hereunder other than for
Cause at any time. In the event of such termination, or in the case of a
material breach of this agreement by the Company, in addition to Final
Compensation and any bonus compensation earned but unpaid for the prior fiscal
year, the Company (i) shall provide the you with six (6) months of severance
pay, at the rate of the Base Salary in effect immediately prior to the
termination, payable in a single lump sum within ten (10) business days
following termination of employment; (ii) shall pay the premium cost of your
participation in the Company's group medical and dental plans for a period of
six (6) months following the date of termination, provided that you are entitled
to continue such participation under applicable law and plan terms; and (iii)
shall cause to become vested twenty-five percent (25%) of the options granted or
otherwise which remain unvested on the date of termination for each year of your
employment with the Company, which vesting shall be effective on the date of
termination, and you shall have not less than ninety (90) days following the
date of termination to exercise all or any portion of such options.

<Page>

FEBRUARY 2005
-- Page 3 OF 5 --

     (c)    Upon a Change of Control

            (i)    If a Change of Control (as defined below) occurs and, within
two (2) years following such Change of Control, the Company terminates your
employment other than for Cause, then, the Company (A) shall provide you with
twenty four (24) months of severance pay, at the rate of the Base Salary in
effect immediately prior to the termination, payable in a single lump sum within
ten (10) business days following termination of employment; (B) shall pay the
premium cost of your participation in the Company's group medical and dental
plans for a period of twenty four (24) months following the date of termination,
provided that you are entitled to continue such participation under applicable
law and plan terms; and (C) shall cause to become vested on the date of
termination 100% of the options granted or otherwise which remain unvested on
that date and you shall be entitled to not less than ninety (90) days following
the date of termination to exercise all or any portion of such options.

            (ii)   In the event that it is determined that any payments or
benefits provided by the Company to you, will be subject to the excise tax
imposed by section 4999 of the Internal Revenue Code or any successor provision
("section 4999"), you may elect either to pay such excise tax or to have such
payments and benefits reduced to the extent necessary so that he shall not be
liable for any such excise tax.

     "Change of Control" means the occurrence hereafter of (i) a sale, merger or
consolidation after which securities possessing more than fifty (50%) percent of
the total combined voting power of the Company's outstanding securities have
been transferred to or acquired by a Person or Persons different from the
Persons who held such percentage of the total combined voting power immediately
prior to such transaction; (ii) the sale, transfer or other disposition of all
or substantially all of the Company's assets to one or more Persons (other than
a wholly owned subsidiary of the Company or a parent company whose stock
ownership after the transaction is the same as the Company's ownership before
the transaction), or (iii) an acquisition, merger or similar transaction or a
divestiture of a substantial portion of the Company's business after which your
role is not substantially the same as such role prior to the transaction

6. COMPETITION AND CONFIDENTIALITY: During the term of your employment, you
agree that you will not engage in any activity that is directly or indirectly
competitive with the Company. Upon your separation from the Company, you agree
to return to the Company all documents or property of the Company, or
reproductions of any such documents or property, developed by you or in your
possession.

In connection with your employment, you will be required to sign the Company's
Standard Confidential Information and Inventions Assignment Agreement (the
"Invention Agreement"), a copy of which is attached with this Letter Agreement.

<Page>

FEBRUARY 2005
-- Page 4 OF 5 --

7. RESTRICTED ACTIVITIES: You agree that some restrictions on your activities
during and after his employment are necessary to protect the goodwill,
Confidential Information and other legitimate interests of the Company which are
also outlined in the Company's Invention Agreement:

            (a)    While you are employed by the Company and for a period of
twelve (12) months after your employment terminates (in the aggregate, the
"Non-Competition Period"), you shall not, directly or indirectly, whether as
owner, partner, investor, consultant, agent, employee, co-venturer or otherwise,
compete with the Company's Business anywhere in the world. The foregoing,
however, shall not prevent or restrict the Employee from owning, directly or
indirectly, not more than five percent (5%) of the voting securities of any
publicly traded company for the sole purpose of a passive investment. For the
purposes of this Section, the Company's Business means researching and
developing a discovery platform that identifies novel, non-obvious combinations
of active molecules that will then become patent-protected therapeutics,
utilizing an automated, high-throughput process to search the combinatorial
space using disease-specific assays.

            (b)    You further agree that, during the Non-Competition Period,
other than on behalf of the Company during your employment hereunder or through
responses to general advertisements and headhunters which, in either case, are
not specifically targeted to Company employees, you will not hire or attempt to
hire any employee of the Company, assist in such hiring by any person, encourage
any such employee to terminate his or her relationship with the Company or
solicit or encourage any person to hire any such employee; solicit or encourage
any independent contractor providing services to the Company to terminate or
diminish its relationship with the Company or solicit or encourage any person to
hire or engage any such independent contractor; or solicit or encourage any
customer, supplier or vendor of the Company to terminate or diminish its
relationship with it, or, in the case of a customer, to conduct with any person
any business or activity which such customer conducts or could conduct with the
Company or any of its affiliates; or solicit or encourage any of the foregoing
to terminate or breach any agreement, written or oral, with the Company or any
of its affiliates.

8. ENFORCEMENT OF COVENANTS You acknowledge that you have carefully read and
considered all the terms and conditions of this letter including the restraints
imposed upon you. The Employee agrees that those restraints are necessary for
the reasonable and proper protection of the Company and that each and every one
of the restraints is reasonable in respect to subject matter, length of time and
geographic area. You further acknowledge that, were you to breach any of the
covenants contained in Sections 7 hereof, the damage to the Company would be
irreparable. You therefore agree that the Company, in addition to any other
remedies available to it, shall be entitled to preliminary and permanent
injunctive relief against any breach or threatened breach by you of any of said
covenants. The parties further agree that, in the event that any provision of
Section 7 hereof shall be determined by any court of competent jurisdiction to
be unenforceable by reason of its being extended over too great a time, too
large a geographic area or too great a range of activities, such provision shall
be deemed to be modified to permit its enforcement to the maximum extent
permitted by law.

<Page>

FEBRUARY 2005
-- Page 5 OF 5 --

If you are in agreement with the above, please indicate your agreement by
signing the enclosed copy of this Letter Agreement and return to Ms. Melinda
Austin at CombinatoRx, Inc.

Sincerely,

/s/ Alexis Borisy

Alexis Borisy
President and CEO
CombinatoRx, Incorporated

The within Letter Agreement is hereby acknowledged, accepted and agreed to:

     Daniel Grau                       Date:    March 7, 2005
-----------------------------------         ---------------------------
Daniel Grau

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00100-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00100-of-00352.parquet"}]]